Company Filing History:
4 out of 4,455 
1 out of 20 Years Active: 2004-2006
Title: Michael K Ahlijanian: Innovator in Pharmaceutical Chemistry
Introduction
Michael K Ahlijanian is a notable inventor based in Mystic, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating various medical conditions. With a total of 4 patents to his name, Ahlijanian's work has the potential to impact numerous therapeutic areas.
Latest Patents
Ahlijanian's latest patents include innovative compounds of imidazole derivatives. These compounds are designed to inhibit cdk5, cdk2, and GSK-3, which are crucial in the treatment of diseases characterized by abnormal cell growth, such as cancer and neurodegenerative disorders. Additionally, his patents address male fertility, diabetes mellitus, metabolic syndrome, and conditions related to mitochondrial function. The pharmaceutical compositions he has developed are aimed at improving health outcomes for a variety of conditions, including hair loss and immunodeficiency.
Career Highlights
Throughout his career, Ahlijanian has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Migenix, Inc. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Ahlijanian has collaborated with notable professionals in his field, including Mark Allen Sanner and Chris John Helal. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Michael K Ahlijanian is a distinguished inventor whose work in pharmaceutical chemistry has the potential to transform treatment options for various medical conditions. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.